TP53 and diabetes mellitus: The proportions of low and high GGH expression cases differed significantly according to the clinical stage, histological grade, primary therapy outcome, race/ethnicity, surgical approach, and TP53 mutation status, but not by residual tumor percentage class, histological type, diabetes status, menopause status, hormone therapy treatment, or radiotherapy treatment.